RXO, Inc. (RXO) PT Lowered to $21 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RXO Hot Sheet
Price: $28.28 +0.14%
Rating Summary:
4 Buy, 17 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
4 Buy, 17 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
TD Cowen analyst Jason Seidl lowered the price target on RXO, Inc. (NYSE: RXO) to $21.00 (from $25.00) while maintaining a Hold rating.
You May Also Be Interested In
- RXO, Inc. (RXO) PT Raised to $30.25 at UBS
- United Therapeutics Corp. (UTHR) PT Raised to $720 at Raymond James
- RXO, Inc. (RXO) PT Raised to $30 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
